Susavion Biosciences Selected To Present At Cavendish Global Health Impact Forum
3/20/2014 6:27:33 AM
Susavion Biosciences, Inc., a company focused on developing immunotherapeutic drugs for Oncology and Infectious Diseases, announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place May 5-7 at the United Nations Headquarters in New York. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences.
Help employers find you! Check out all the jobs and post your resume.
comments powered by